Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways

Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides

(2016) Tom J.N. Hermans et al.   EUROPEAN UROLOGY

Peroxiredoxins in Regulation of MAPK Signalling Pathways; Sensors and Barriers to Signal Transduction

(2016)   MOLECULES AND CELLS

Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways

(2015) Xin-xin Xiong et al.   ACTA PHARMACOLOGICA SINICA

Comparison of the effects of 12 months of monthly minodronate monotherapy and monthly minodronate combination therapy with vitamin K2 or eldecalcitol in patients with primary osteoporosis

(2015) Kosuke Ebina et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Improving indication, technique and outcome of radical cystectomy

(2015) J. Alfred Witjes   Nature Reviews Urology

ROS-Induced JNK and p38 Signaling Is Required for Unpaired Cytokine Activation during Drosophila Regeneration

(2015) Paula Santabárbara-Ruiz et al.   PLoS Genetics

Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy

(2015) Michael A. Feuerstein et al.   Current Urology Reports

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis

(2014) Y Shi et al.   CELL DEATH AND DIFFERENTIATION

Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives

(2014) Shaista Hafeez et al.   Expert Review of Anticancer Therapy

Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis

(2014) Martin J. Shearer et al.   JOURNAL OF LIPID RESEARCH

Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: Therapeutic perspectives

(2014) Sabzali Javadov et al.   PHARMACOLOGY & THERAPEUTICS

Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer

(2014) Scott M. Stevenson et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Compound K Induces Apoptosis of Bladder Cancer T24 Cells Via Reactive Oxygen Species-Mediated p38 MAPK Pathway

(2013) Han Wang et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Vitamin K2, a Naturally Occurring Menaquinone, Exerts Therapeutic Effects on Both Hormone-Dependent and Hormone-Independent Prostate Cancer Cells

(2013) Abhilash Samykutty et al.   Evidence-based Complementary and Alternative Medicine

CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction

(2013) Chun-Ru Yang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis

(2012) Angelina V. Vaseva et al.   CELL

Inhibition of MKK7–JNK by the TOR Signaling Pathway Regulator-Like Protein Contributes to Resistance of HCC Cells to TRAIL-Induced Apoptosis

(2012) In Sung Song et al.   GASTROENTEROLOGY

Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells

(2011) Ga Bin Park et al.   CANCER LETTERS

Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway

(2010) Songgang Li et al.   CANCER LETTERS

Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo

(2010) Gang Wei et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme

(2010) Kimie Nakagawa et al.   NATURE

PUMA, a potent killer with or without p53

(2009) J Yu et al.   ONCOGENE